Skip to main navigation Skip to search Skip to main content

Study of Natalizumab in Combination with Glatiramer Acetate(GA) in Subjects with Relapsing-Remitting Multiple Sclerosis (MS)

Project: Research

Project Details

StatusFinished
Effective start/end date05/13/0304/11/05

Funding

  • Biogen IDEC: $63,975.00